Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · see citing works

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,338 · see citing works

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,447 · see citing works

RING Finger Proteins

Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · see citing works

The IARC TP53 database: new online mutation analysis and recommendations to users

Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248 · see citing works

Decision making by p53: life, death and cancer

Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,063 · see citing works

Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53

Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044 · see citing works

Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804 · see citing works

The p53–Mdm2 module and the ubiquitin system

Michael, D., & Oren, M. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00099-8 · Cited by 759 · see citing works

The P53 pathway: what questions remain to be explored?

Levine, A. J., Hu, W., & Feng, Z. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401910 · Cited by 654 · see citing works

p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2

Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582 · see citing works

Transcriptional regulation by p53: one protein, many possibilities

Laptenko, O., & Prives, C. L. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 500 · see citing works

Ex vivo expansion, adipogenesis and neurogenesis of cryopreserved human bone marrow mesenchymal stem cells

Xiang, Y., Zheng, Q., Jia, B., Huang, G., Xie, C., Pan, J., & Wang, J. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2006.11.012 · Cited by 429 · see citing works

Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase

Honda, R., & Yasuda, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203464 · Cited by 376 · see citing works

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361 · see citing works

Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4

Marine, J.-C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., & Lozano, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401912 · Cited by 352 · see citing works

MDM2 interacts with MDMX through their RING finger domains

Tanimura, S., Ohtsuka, S., Mitsui, K., Shirouzu, K., Yoshimura, A., & Ohtsubo, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00254-9 · Cited by 324 · see citing works

Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans

Linke, K., Mace, P. D., Smith, C. A., Vaux, D. L., Silke, J., & Day, C. L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402309 · Cited by 288 · see citing works

Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein

Sharp, D. A., Kratowicz, S. A., Sank, M. J., & George, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38189 · Cited by 286 · see citing works

C-Terminal Ubiquitination of p53 Contributes to Nuclear Export

Lohrum, M. A. E., Woods, D. B., Ludwig, R. L., Bálint, É., & Vousden, K. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8521-8532.2001 · Cited by 237 · see citing works

Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., & Jochemsen, A. G. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve227 · Cited by 234 · see citing works

C-terminal modifications regulate MDM2 dissociation and nuclear export of p53

Carter, S., Bischof, O., Dejean, A., & Vousden, K. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1562 · Cited by 225 · see citing works

The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity

Poyurovsky, M. V., Priest, C., Kentsis, A., Borden, K. L., Pan, Z., Pavletich, N., & Prives, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601465 · Cited by 203 · see citing works

A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network

Toledo, F., Krummel, K. A., Lee, C. J., Liu, C.-W., Rodewald, L.-W., Tang, M., & Wahl, G. M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.014 · Cited by 199 · cited 1× · see citing works

MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins

Kobet, E., Zeng, X., Zhu, Y., Keller, D., & Lu, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12547 · Cited by 193 · see citing works

An essential function of the extreme C-terminus of MDM2 can be provided by MDMX

Uldrijan, S., Pannekoek, W., & Vousden, K. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601469 · Cited by 170 · see citing works

RING Domain–Mediated Interaction Is a Requirement for MDM2's E3 Ligase Activity

Kawai, H., Lopez-Pajares, V., Kim, M. M., Wiederschain, D., & Yuan, Z.-M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1313 · Cited by 156 · see citing works

Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2

de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., & Jochemsen, A. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213034200 · Cited by 143 · cited 1× · see citing works

DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation

Okamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9608-9620.2005 · Cited by 129 · see citing works

Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export

Gu, J., Nie, L., Wiederschain, D., & Yuan, Z.-M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8533-8546.2001 · Cited by 100 · see citing works

What have animal models taught us about the p53 pathway?

Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 76 · see citing works

Hetero-oligomerization with MdmX Rescues the Ubiquitin/Nedd8 Ligase Activity of RING Finger Mutants of Mdm2

Singh, R. K., Iyappan, S., & Scheffner, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610879200 · Cited by 69 · see citing works

Regulation of p53 by Mdm2

Shmueli, A., & Oren, M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00529-x · Cited by 51 · see citing works

Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2

Ohtsubo, C., Shiokawa, D., Kodama, M., Gaiddon, C., Nakagama, H., Jochemsen, A. G., Taya, Y., & Okamoto, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01180.x · Cited by 32 · see citing works

Hydrogen peroxide sensing, signaling and regulation of transcription factors

Marinho, H. S., Real, C., Cyrne, L., Soares, H., & Antunes, F. (2014) · Redox Biology · doi:10.1016/j.redox.2014.02.006 · Cited by 851 · see citing works

The p53 orchestra: Mdm2 and Mdmx set the tone

Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works

RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis

Lipkowitz, S., & Weissman, A. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3120 · Cited by 415 · see citing works

The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation

Weissman, A. M., Shabek, N., & Ciechanover, A. J. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3173 · Cited by 318 · see citing works

Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms

de Bie, P., & Ciechanover, A. J. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.16 · Cited by 304 · see citing works

Surf the Post-translational Modification Network of p53 Regulation

Gu, B., & Zhu, W. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4283 · Cited by 234 · see citing works

p53-family proteins and their regulators: hubs and spokes in tumor suppression

Collavin, L., Lunardi, A., & Sal, G. D. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.35 · Cited by 219 · see citing works

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

Pant, V., Xiong, S., Iwakuma, T., Quintás-Cardama, A., & Lozano, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102241108 · Cited by 134 · see citing works

The roles and regulation of MDM2 and MDMX: it is not just about p53Preprint

Klein, A. M., de Queiroz, R. M., Venkatesh, D., & Prives, C. L. (2021) · Genes & Development · doi:10.1101/gad.347872.120 · Cited by 132 · see citing works

MDM2 and MDMX: Alone and together in regulation of p53.

Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125 · see citing works

MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination

Wang, X., Wang, J., & Jiang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213868 · Cited by 115 · see citing works

Mdm2 and MdmX partner to regulate p53

Wang, X., & Jiang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.049 · Cited by 111 · see citing works

Retinoblastoma: Etiology, Modeling, and Treatment

Kaewkhaw, R., & Rojanaporn, D. (2020) · Cancers · doi:10.3390/cancers12082304 · Cited by 108 · see citing works

Changes in PUB22 Ubiquitination Modes Triggered by MITOGEN-ACTIVATED PROTEIN KINASE3 Dampen the Immune Response

Furlan, G., Nakagami, H., Eschen‐Lippold, L., Jiang, X., Majovsky, P., Kowarschik, K., Hoehenwarter, W., Lee, J., & Trujillo, M. (2017) · The Plant Cell · doi:10.1105/tpc.16.00654 · Cited by 92 · see citing works

Validation of MdmX as a therapeutic target for reactivating p53 in tumors

Garcia, D., Warr, M. R., Martins, C. P., Brown Swigart, L., Passegué, E., & Evan, G. I. (2011) · Genes & Development · doi:10.1101/gad.16722111 · Cited by 83 · see citing works

Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2

Nie, J., Xie, P., Liu, L., Xing, G., Chang, Z., Yin, Y., Tian, C., He, F., & Zhang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126920 · Cited by 79 · see citing works

Extensive Post-translational Modification of Active and Inactivated Forms of Endogenous p53

DeHart, C. J., Chahal, J. S., Flint, S. J., & Perlman, D. H. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030254 · Cited by 70 · see citing works

The long and the short of it: the MDM4 tail so far

Haupt, S., Mejía-Hernández, J. O., Vijayakumaran, R., Keam, S. P., & Haupt, Y. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz007 · Cited by 69 · see citing works

Regulation of the p53 pathway by ubiquitin and related proteins

Hock, A., & Vousden, K. H. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.011 · Cited by 69 · see citing works

Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage

Tollini, L. A., Jin, A., Park, J., & Zhang, Y. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.006 · Cited by 66 · see citing works

The RING‐type ubiquitin ligases Pex2p, Pex10p and Pex12p form a heteromeric complex that displays enhanced activity in an ubiquitin conjugating enzyme‐selective manner

Magraoui, F. E., Bäumer, B. E., Platta, H. W., Baumann, J. S., Girzalsky, W., & Erdmann, R. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08591.x · Cited by 65 · see citing works

Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73

Zdzalik, M., Pustelny, K., Kędracka–Krok, S., Huben, K., Pęcak, A., Władyka, B., Jankowski, S., Dubin, A., Potempa, J., & Dubin, G. (2010) · Cell Cycle · doi:10.4161/cc.9.22.13871 · Cited by 65 · see citing works

Alterations of p63 and p73 in Human Cancers

Inoue, K., & Fry, E. A. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_2 · Cited by 58 · see citing works

Clinical utility of anti-p53auto-antibody: Systematic review and focus on colorectal cancer

Suppiah, A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i29.4651 · Cited by 59 · see citing works

HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity

Phillips, A., Teunisse, A., Lam, S., Lodder, K., Darley, M., Emaduddin, M., Wolf, A., Richter, J., de Lange, J., Verlaan-de Vries, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129726 · Cited by 55 · see citing works

Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy

Vlatković, N., Boyd, M. T., & Rubbi, C. P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1361-x · Cited by 53 · see citing works

The exportomer: the peroxisomal receptor export machinery

Platta, H. W., Hagen, S., & Erdmann, R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1136-9 · Cited by 52 · see citing works

Comprehensive Analysis of the Rice RING E3 Ligase Family Reveals Their Functional Diversity in Response to Abiotic stress

Lim, S.-B., Hwang, J. G., Jung, C. G., Hwang, S., Moon, J., & Jang, C. S. (2013) · DNA Research · doi:10.1093/dnares/dst011 · Cited by 52 · see citing works

Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer

Swetzig, W. M., Wang, J., & Das, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7533 · Cited by 42 · see citing works

Anatomy of Mdm2 and Mdm4 in evolution

Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40 · see citing works

MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation In Vivo

Yang, J., Jin, A., Han, J., Chen, X., Zheng, J., & Zhang, Y. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0790 · Cited by 39 · see citing works

Short Hairpin RNA Library-Based Functional Screening Identified Ribosomal Protein L31 That Modulates Prostate Cancer Cell Growth via p53 Pathway

Maruyama, Y., Miyazaki, T., Ikeda, K., Okumura, T., Sato, W., Horie‐Inoue, K., Okamoto, K., Takeda, S., & Inoue, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108743 · Cited by 38 · see citing works

On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: A Brownian dynamics study

ElSawy, K. M., Verma, C. S., Joseph, T. L., Lane, D. P., Twarock, R., & Caves, L. S. D. (2013) · Cell Cycle · doi:10.4161/cc.23511 · Cited by 37 · see citing works

The roles of MDM2 and MDMX phosphorylation in stress signaling to p53

Chen, J. (2012) · Genes & Cancer · doi:10.1177/1947601912454733 · Cited by 33 · see citing works

The MID1 E3 Ligase Catalyzes the Polyubiquitination of Alpha4 (α4), a Regulatory Subunit of Protein Phosphatase 2A (PP2A)

Du, H., Huang, Y., Zaghlula, M., Walters, E., Cox, T. C., & Massiah, M. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.481093 · Cited by 33 · see citing works

Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers

Doleželová, P., Cetkovská, K., Vousden, K. H., & Uldrijan, S. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19445 · Cited by 33 · see citing works

Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma

Reis, A. H. D. O., de Carvalho, I. N. S. R., Damasceno, P. B. D. S., Ferman, S., Lucena, E., López‐Camelo, J. S., Seuánez, H. N., & Vargas, F. R. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24014 · Cited by 33 · see citing works

E3 ubiquitin ligase IPI1 controls rice immunity and flowering via both E3 ligase-dependent and -independent pathways

Yi, H., Shi, H., Mao, W., Yin, J., Ma, Y., Li, X., Jing, L., He, M., Zhu, X., Lu, X., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.06.014 · Cited by 30 · see citing works

Stochastic and Deterministic Models of Cellular p53 Regulation

Leenders, G. B., & Tuszyński, J. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00064 · Cited by 28 · see citing works

Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer Cells

Zhang, S., Yan, Z., Li, Y., Gong, Y., Lyu, X., Lou, J., Zhang, D., Meng, X., & Zhao, Y. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00095 · Cited by 29 · see citing works

Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition

Shin, J., Ha, J., Lee, D.-H., Ryu, K., Bae, K., Park, B. C., Park, S. G., Yi, G., & Chi, S. (2015) · Cell Cycle · doi:10.1080/15384101.2014.998056 · Cited by 27 · see citing works

MDMX exerts its oncogenic activity via suppression of retinoblastoma protein

Zhang, H., Hu, L., Qiu, W., Deng, T., Zhang, Y., Bergholz, J. S., & Xiao, Z.-X. (2015) · Oncogene · doi:10.1038/onc.2015.11 · Cited by 26 · see citing works

MdmX Is Required for p53 Interaction with and Full Induction of the Mdm2 Promoter after Cellular Stress

Biderman, L., Poyurovsky, M. V., Assia, Y., Manley, J. L., & Prives, C. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06150-11 · Cited by 26 · see citing works

The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target

Fierabracci, A., & Pellegrino, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121975 · Cited by 26 · see citing works

Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways

Jacob, A. G., Singh, R. K., Comiskey, D. F., Rouhier, M. F., Mohammad, F., Bebee, T. W., & Chandler, D. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104444 · Cited by 24 · see citing works

Regulation of MDM4

Markey, M. P. (2010) · Frontiers in bioscience · doi:10.2741/3780 · Cited by 24 · see citing works

The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review

Jiang, H., Luo, J., & Lei, H. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108910 · Cited by 23 · see citing works

Cbl-c Ubiquitin Ligase Activity Is Increased via the Interaction of Its RING Finger Domain with a LIM Domain of the Paxillin Homolog, Hic 5

Ryan, P. E., Kales, S. C., Yadavalli, R., Nau, M. M., Zhang, H., & Lipkowitz, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049428 · Cited by 21 · see citing works

MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage

Conza, G. D., Mancini, F., Buttarelli, M., Pontecorvi, A., Trimarchi, F., & Moretti, F. (2012) · Cell Cycle · doi:10.4161/cc.11.4.19208 · Cited by 21 · see citing works

p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity

Arena, A., Stigliano, A., Belcastro, E., Giorda, E., Rosado, M. M., Grossi, A., Assenza, M. R., Moretti, F., & Fierabracci, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728381 · Cited by 17 · see citing works

MDM2 oligomers: antagonizers of the guardian of the genome

Leslie, P. L., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.88 · Cited by 17 · see citing works

Regulation of MDM4 (MDMX) function by p76MDM2: a new facet in the control of p53 activity

Giglio, S., Mancini, F., Pellegrino, M., Conza, G. D., Puxeddu, E., Sacchi, A., Pontecorvi, A., & Moretti, F. (2010) · Oncogene · doi:10.1038/onc.2010.324 · Cited by 16 · see citing works

Differential expression of microRNA501‐5p affects the aggressiveness of clear cell renal carcinoma

Mangolini, A., Bonon, A., Volinia, S., Lanza, G., Gambari, R., Pinton, P., Russo, G. R., SENNO, L. D., Dell’Atti, L., & Aguiari, G. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.10.016 · Cited by 17 · see citing works

Deconstructing nucleotide binding activity of the Mdm2 RING domain

Priest, C., Prives, C. L., & Poyurovsky, M. V. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq669 · Cited by 16 · see citing works

Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells

Balmer, M. T., Katz, R. D., Liao, S., Goodwine, J. S., & Gal, S. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.29112 · Cited by 16 · see citing works

Ubiquitination of p53 is Involved in Troglitazone Induced Apoptosis in Cervical Cancer Cells

Chen, H., Zhang, D., Wu, J.-X., Pei, D., & Zheng, J.-N. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.5.2313 · Cited by 12 · see citing works

Ubiquitination-dependent degradation of p73 by the mitochondrial E3 ubiquitin ligase Hades

Min, B., Ryu, J., Chi, S., & Yi, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.163 · Cited by 12 · see citing works

Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients

Pellegrino, M., Traversi, G., Arena, A., Cappa, M., Rosado, M. M., Andreani, M., Delfino, D. V., Moretti, F., & Fierabracci, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228296 · Cited by 12 · see citing works

Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice

Tian, H., Tackmann, N. R., Jin, A., Zheng, J., & Zhang, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000122 · Cited by 9 · see citing works

To Grow, Stop or Die? – Novel Tumor-Suppressive Mechanism Regulated by the Transcription Factor E2F

Ozono, E., Yamaoka, S., & Ohtani, K. (2013) · InTech eBooks · doi:10.5772/54510 · Cited by 8 · see citing works

1H, 15N and 13C backbone resonance assignments of the acidic domain of the human MDMX protein

Song, Q., Liu, X., & Rainey, J. K. (2022) · Biomolecular NMR Assignments · doi:10.1007/s12104-022-10081-8 · Cited by 8 · see citing works

Future Aspects of Tumor Suppressor Gene

Cheng, Y. (2013) · InTech eBooks · doi:10.5772/56471 · Cited by 8 · see citing works

Intra molecular interactions in the regulation of p53 pathway

Chen, J. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.09.23 · Cited by 5 · see citing works

The MDMX acidic domain competes with the p53 transactivation domain for MDM2 N-terminal domain binding

Song, Q., Liu, X., & Rainey, J. K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119319 · Cited by 4 · see citing works

MDM4: What do we know about the association between its polymorphisms and cancer?

Almeida, G. M., Castilho, A. C., Adamóski, D., & Braun-Prado, K. (2022) · Medical Oncology · doi:10.1007/s12032-022-01929-z · Cited by 4 · see citing works

MDMX under stress: the MDMX-MDM2 complex as stress signals hub

de Polo, A., Vivekanandan, V., Little, J. B., & Yuan, Z.-M. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.12.18 · Cited by 4 · see citing works

First reported advanced pancreatic cancer with hyperprogression treated with PD-1 blockade combined with chemotherapy: a case report and literature review

Wang, Y., Peng, M.-Z., Xu, Y.-L., Ying, Y., Tang, L.-H., Xu, H., He, J., Liu, L., & Wang, W.-Q. (2024) · Discover Oncology · doi:10.1007/s12672-024-01420-3 · Cited by 3 · see citing works

Length matters

Poyurovsky, M. V. (2012) · Cell Cycle · doi:10.4161/cc.20047 · Cited by 3 · see citing works

Structural Insights into Substrate Binding and Regulation of E3 Ubiquitin Ligases in the Nedd4 Family using NMR Spectroscopy

Pascual, A. E. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)

Molecular analysis of the domain with no name (DWNN)/RBBP6 in human cancers

Mbita, Z. (2012) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)

IN VIVO SIGNIFICANCE OF THE MDM4 AND P73 INTERACTION DURING DEVELOPMENT AND TUMORIGENESIS

Tashakori, M. (2015) · Digital Commons-TMC (Texas Medical Center)

Characterization of synthetic lethality between Mdm2 overexpression and genotoxic agents and identification of a novel function of the Mdmx oncogene in DNA repair

Carrillo, A. M. (2014)

Faculty Opinions recommendation of Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.

Hoppe, T. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.721685355.793570374

Das Onkoprotein Mdm4 und seine Wirkung auf die DNA-Replikation

Wohlberedt, K. (2024) · doi:10.53846/goediss-10645

First Reported Advanced Pancreatic Cancer With Hyperprogression Treated With PD-1 Blockade combined with chemotherapy: A Case Report And Literature ReviewPreprint

Wang, Y., Peng, M.-Z., Xu, Y.-L., Ying, Y., Tang, L.-H., Xu, H., He, J., Liu, L., & Wang, W.-Q. (2024) · Research Square · doi:10.21203/rs.3.rs-4673771/v1

Implication de ROQUIN dans la physiopathologie du lymphome T angio-immunoblastique

Auguste, T. (2012) · theses.fr (ABES) · doi:10.70675/db1f2eeez04bez4837za71dzf7b77bc522d6

BindingDB Entry 50017816: Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer Cells.

BindingDB (2023) · UC San Diego · doi:10.7270/q2v69pp3

New insight into the role of MDMX in MDM2-mediated p53 degradation and anti-cancer drug development

Yang, J., & Zhang, Y. (2021) · Oncoscience · doi:10.18632/oncoscience.542

Analysis of MDM2 and MDMX domains involved in p53 ubiquitylation and degradation

Uldrijan, S., & Vousden, K. H. (2007)

MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination

Badciong, J. C., & Haas, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208593200 · Cited by 106 · see citing works

Modification of MDMX by Ubiquitination and Sumoylation

Pan, Y. (2005) · Digital Commons - University of South Florida (University of South Florida)

MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination

Wang, X., Wang, J., & Jiang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213868 · Cited by 115 · see citing works